Next Quarterly Earnings
Monday, October 19, 2026
Expected
Celltrion
Celltrion, a leading South Korean biopharmaceutical company, develops and manufactures innovative biosimilars and novel drugs. The company focuses on research and development to provide patient-centric therapies for global healthcare needs. Utilizing cutting-edge biotechnology, Celltrion enhances access to high-quality pharmaceutical solutions worldwide.
Recap: the latest results
Celltrion (068270) reported its Q3 2026 financial results on July 3, 2026, before market open. The company's earnings per share (EPS) came in at 1,351.86 KRW, which missed the analyst estimate of 1,450.51 KRW by 6.8%. Celltrion reported a revenue of 1,305,000 million KRW, and the stock price reacted with an increase of 3.96% after the release.
Generated automatically from our data — as of 07/12/2026
Frequently asked questions
When did Celltrion last report quarterly earnings?
Celltrion last reported quarterly earnings on 7/3/2026 (Q3 2026). Earnings per share (EPS) came in at 1,351.86 KRW.
How often has Celltrion beaten expectations?
Celltrion has beaten analyst EPS estimates in 2 of its last 3 evaluated quarters (beat rate: 66.7%).
How do I add the Celltrion earnings dates to my calendar?
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
All Dates
Earnings statistics
Estimates vs. results
2/3
Quarters above estimates
66.7%
Beat rate
+18.6%
Avg. EPS surprise
Basis: 3 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.
Company Information
Name
Celltrion
Country
🇰🇷
More Financial Information